Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

INTRODUCTION: Ritlecitinib demonstrated efficacy in patients with alopecia areata (AA) in the ALLEGRO phase 2b/3 study (NCT03732807). However, hair loss presentation may vary based on location (e.g., scalp, eyebrow/eyelash, body). Here, we sought to identify distinct hair loss profiles at baseline a...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaçi, Diamant, Tziotzios, Christos, Ito, Taisuke, Ko, Justin, Karadağ, Ayşe Serap, Fang, Hong, Edwards, Roger A., Bonfanti, Gianluca, Wolk, Robert, Tran, Helen, Law, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613177/
https://www.ncbi.nlm.nih.gov/pubmed/37707764
http://dx.doi.org/10.1007/s13555-023-00997-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613177/
https://www.ncbi.nlm.nih.gov/pubmed/37707764
http://dx.doi.org/10.1007/s13555-023-00997-x

Ejemplares similares